In this study, we aimed to screen and identify differentially expressed proteins in very early HCC and AFP-negative HCC and evaluate the feasibility of using autoantibodies against these identified antigens to predict hepatocarcinogenesis with premalignant liver disease, such as LC. This evidence concerns the gene AFP and hepatocellular carcinoma.